Article Figures & Data
Figures
- Figure 1.
SVR12 Rates in Cirrhotic HCV1a-Infected Treatment-Naïve and Treatment-Experienced Patients Treated for 12 or 24 Weeks
3D, 3-drug direct-acting antiviral regimen; HCV1a, hepatitis C virus genotype 1a; PegIFN, pegylated interferon; RBV, ribavirin; SVR12, sustained virologic response at week 12.
Tables
Tools
SVR after Treatment of HCV Genotype 1a with ABT-450/Ritonavir, Ombitasvir, and Dasabuvir is Enhanced by RBV in Noncirrhotic Patients and by Extension of Duration in Cirrhotic Patients
Permalink:
Table of contents
Cited By...
- No citing articles found.